Orthopedic management of skeletal metastases

Nokitaka Setsu, Eisuke Kobayashi, Akira Kawai

研究成果: Contribution to journalArticle査読

1 被引用数 (Scopus)

抄録

Recent advances in drug therapy for metastatic bone diseases are changing the indications for surgical treatments. Bone-modifying agents, including bisphosphonates and denosumab, have reduced skeletal-related events. Meanwhile, novel anticancer drugs that have been developed, especially molecular-targeted drugs, can improve the prognoses of patients with bone metastases, thereby potentially increasing the number of patients who could receive benefits from surgeries for metastases. A multidisciplinary approach and the early involvement of surgeons are required for the application of adequate orthopedic treatments, including braces, rehabilitation, and surgeries for local tumor control, palliative fixation, and spinal decompression.

本文言語英語
ページ(範囲)1350-1354
ページ数5
ジャーナルJapanese Journal of Cancer and Chemotherapy
42
11
出版ステータス出版済み - 11 1 2015
外部発表はい

All Science Journal Classification (ASJC) codes

  • 医学(全般)

フィンガープリント

「Orthopedic management of skeletal metastases」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル